Skip to main content
Ambey Laboratories Limited Logo

Ambey Laboratories Limited

Offer PeriodJul 04, 2024 – Jul 08, 2024
Listed Price
₹85.00
+25.00%
Price Band₹65 - ₹68
Lot Size2,000 Shares
Allotment DateJul 09, 2024
Listing DateJul 11, 2024
Subscription159.71 Times
Issue Size₹44.68 Cr

IPO Details

Subscription

lot distribution

Lot Distribution

reservation

Reservation

company financials

Company Fin.

₹28
(41.18%)

Premium (ELP)

Ambey Laboratories Limited's successfully completed its Initial Public Offering and commenced trading on Jul 11, 2024 at the NSE exchange. The company raised 65,70,000 Shares through this public offering, comprising 59,28,000 Shares in fresh capital and ₹2.12 Cr through the Offer for Sale mechanism.

The IPO was priced within the band of ₹65 to ₹68, with minimum application lots of 2000 shares. The offering attracted significant investor interest during its subscription period from Jul 04, 2024 to Jul 08, 2024.

Share allotment was finalized on Jul 09, 2024, distributing equity to successful applicants. The stock's subsequent listing marked a significant milestone in the company's corporate history, providing public market liquidity to shareholders.

Ambey Laboratories IPO Details
IPO Date
:
Jul 04, 2024 to Jul 08, 2024
Allotment Date
:
Jul 09, 2024
List Date
:
Jul 11, 2024
Lot Size
:
2,000 share
Issue Price
:
₹65 - ₹68
Issue Size
:
65,70,000 (aggregating up to 44.68 Cr)
Fresh Issue
:
59,28,000 (aggregating up to 40.31 Cr)
Offer For Sale
:
3,12,000 (aggregating up to 2.12 Cr)
Listing At
:
NSE
Share Holding Pre-Issue
:
1,86,88,819
Share Holding Post-Issue
:
2,52,40,819
Market Marker Portion
:
3,30,000
First time applying for an IPO? Read our guide on How to Apply for an IPO & Bidding Timings.
Lot(s) Distribution

Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.

IPO Reservation
Shares65,70,000
RETAIL
33.24%(21,84,000)
NII (HNI)
14.25%(9,36,000)
QIB
19.05%(12,52,000)
Anchor
28.44%(18,68,000)
Market Maker
5.02%(3,30,000)
Total
100.00%(65,70,000)
Ambey Laboratories IPO Key Performance Indicators
Want to understand how to evaluate these metrics? Read our guide on IPO Key Performance Indicators (KPIs).
Company Financials (in Lakhs)
Ambey Laboratories IPO About Company

Ambey Laboratories, incorporated in 1985, is a leading agrochemical manufacturer specializing in crop protection solutions and has been a key player in the industry for nearly four decades. Operating from its ISO 9001:2015 and ISO 14001:2015 certified facility in Behror, Rajasthan, the company is renowned for producing and supplying 2,4-D base chemicals and a diverse range of agrochemical formulations, including herbicides, insecticides, and fungicides. Its product portfolio features 2,4-D Acid 98% TC, 2,4-D Sodium 95% SP, 2,4-D Amine, Chlorpyriphos, Thiamethoxam, Pretilachlor, Metribuzin, Hexaconazole, and Metalaxyl, among others, catering to domestic and international markets. With a workforce of 220 employees as of October 31, 2023, Ambey Laboratories serves prominent corporate clients such as Aromatic Rasayan Private Limited, JR Jindal Infraprojects Private Limited, and SC Formulator Co. Ltd., reinforcing its position as a trusted supplier in the agrochemical sector.

Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."

Ambey Laboratories IPO Strength Factors
  1. Strategic Manufacturing Location: The Behror, Rajasthan facility provides logistical advantages, improving market reach and operational efficiency.
  2. Commitment to Quality: ISO 9001:2015 and ISO 14001:2015 certifications ensure high-quality, environmentally responsible agrochemical products.
  3. Strong Supplier Relations: Established, reliable partnerships with suppliers secure a steady flow of raw materials, supporting operational stability.
⚠️Ambey Laboratories IPO Risk Factors
  1. Frozen Promoter Demat Account: SEBI's freeze on the promoter's demat account (as per the 11.02.2021 letter) raises concerns over corporate governance and financial stability, with details on reasons and duration unavailable.
  2. Client Concentration Risk: Heavy reliance on a few key clients makes revenue vulnerable; losing a major client could significantly impact business operations and profitability.
  3. Seasonal Business Fluctuations: Operations are affected by seasonal demand variations, influencing production, inventory management, and financial performance.
🏦Ambey Laboratories IPO Lead Manager(s)
Fast Track Finsec Private Limited
👤Ambey Laboratories IPO Promoter(s)
  1. Archit Gupta
  2. Arpit Gupta
  3. Sarina Gupta
  4. Rishita Gupta
🏢Ambey Laboratories IPO Company Details

Ambey Laboratories Limited

Phone: 0124-4000788
address:Ground Floor, Property No.555 Tarla Mohalla, Ghitorni, West Delhi, New Delhi, -110030
📋Ambey Laboratories IPO Registrar

Link Intime India Private Limited

Name:Link Intime India Private Limited
Phone:+91-22-4918 6270
Ambey Laboratories IPO FAQs
IPO Trend Assistant
Online
Powered by IPO Trend